Please try another search
For the nine months ended 30 September 2020,Neurotrope Inc revenues was not reported. Net lossdecreased 22% to $9.7M. Lower net loss reflects Researchand development decrease of 76% to $1M (expense),Stock-based compensation decrease of 55% to $1.4M (expense), Stock-based compensation - related party decrease of 88%to $21K (expense). Basic Earnings per Share excludingExtraordinary Items increased from -$0.97 to -$0.45.
Period Ending: | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Total Revenue | 0 | 0 | 0 | 0 |
Gross Profit | ||||
Operating Income | -2.58 | -3.01 | -2.61 | -2.69 |
Net Income | -4.27 | -2.93 | -2.54 | -2.61 |
Period Ending: | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Total Assets | 29.15 | 30.87 | 32.52 | 17.9 |
Total Liabilities | 1.3 | 1.07 | 0.35 | 0.48 |
Total Equity | 27.85 | 29.8 | 32.18 | 17.42 |
Period Ending: | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 |
---|---|---|---|---|
Period Length: | 9 Months | 6 Months | 3 Months | 12 Months |
Cash From Operating Activities | -6.9 | -3.65 | -1.74 | -11.89 |
Cash From Investing Activities | -0.01 | -0.01 | -0 | -0.01 |
Cash From Financing Activities | 16.52 | 16.52 | 16.52 | 0.42 |
Net Change in Cash | 9.62 | 12.87 | 14.78 | -11.47 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review